245 filings
Page 3 of 13
8-K
xrmqcnsc0 u2eenmcm
14 Dec 22
Other Events
8:29pm
424B5
yov0dm9bn51252zltyo
14 Dec 22
Prospectus supplement for primary offering
8:25pm
RW
m23bxuw306 rnu1c
12 Dec 22
Registration withdrawal request
8:00am
8-K
apqg ipx39wxeo
7 Dec 22
Regulation FD Disclosure
4:15pm
8-K
7vm55b
6 Dec 22
BioVie Announces Positive Results for NE3107 in Parkinson’s and Alzheimer’s Phase 2 Trials
6:05am
8-K
g2kh 7wfx3ge
5 Dec 22
Other Events
9:47pm
424B5
qnp8b98zssn47
5 Dec 22
Prospectus supplement for primary offering
9:45pm
8-K
8mq2ig0ur317vnvcxgna
10 Nov 22
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
pkqhv90
4 Oct 22
BioVie Issues Letter to Shareholders
9:58pm
424B5
dc4vvibp5zf
30 Sep 22
Prospectus supplement for primary offering
5:15pm
8-K/A
zm868nydui6owqzma6o
7 Sep 22
BioVie and Dr. Sheldon Jordan Jointly Announce Topline Results from an
5:17pm
8-K
10tyser
7 Sep 22
BioVie and Dr. Sheldon Jordan Jointly Announce Topline Results from an
6:05am
8-K
okwv8cdx ag21cxjekmq
31 Aug 22
Entry into a Material Definitive Agreement
5:15pm
424B5
jetnp gxl6ajhbksfod
31 Aug 22
Prospectus supplement for primary offering
5:10pm
D
39zrsx
25 Jul 22
$6M in equity / options / securities to be acquired, sold $6M, 1 investor
11:22am
DEF 14C
yvyc2bca
25 Jul 22
Information statement
7:00am